Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.8% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.54% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRFT
1551
DELISTED
Perficient Inc
PRFT
| $2.63M | ﹤0.01% |
73,500
+10,300
| +16% | +$342K |
|
|
AVYA
1552
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.63M | ﹤0.01% |
212,700
-2,900
| -1% | -$33.4K |
|
1553
Sinclair Inc
SBGI
$1.03B
| $2.63M | ﹤0.01% |
142,350
+12,200
| +9% | +$212K |
|
|
MRSN
1554
DELISTED
Mersana Therapeutics
MRSN
| $2.62M | ﹤0.01% |
+4,484
| New | +$1.53M |
|
1555
Middlesex Water
MSEX
$1.11B
| $2.61M | ﹤0.01% |
38,862
+5,100
| +15% | +$323K |
|
1556
DigitalBridge
DBRG
$2.95B
| $2.61M | ﹤0.01% |
271,775
+47,450
| +21% | +$412K |
|
|
SVC
1557
Service Properties Trust
SVC
$1.06B
| $2.6M | ﹤0.01% |
73,458
+9,620
| +15% | +$335K |
|
|
SWAV
1558
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $2.6M | ﹤0.01% |
54,900
+39,800
| +264% | +$1.64M |
|
1559
Genworth Financial
GNW
$3.77B
| $2.6M | ﹤0.01% |
1,124,986
+148,600
| +15% | +$468K |
|
1560
Kaiser Aluminum
KALU
$2.99B
| $2.6M | ﹤0.01% |
35,300
+4,500
| +15% | +$321K |
|
1561
Regenxbio
RGNX
$704M
| $2.6M | ﹤0.01% |
70,500
+6,100
| +9% | +$227K |
|
1562
Sphere Entertainment
SPHR
$6.33B
| $2.6M | ﹤0.01% |
+34,633
| New | +$2.66M |
|
1563
Rush Enterprises Class A
RUSHA
$9.62B
| $2.6M | ﹤0.01% |
140,850
+19,125
| +16% | +$319K |
|
1564
Carpenter Technology
CRS
$26.6B
| $2.59M | ﹤0.01% |
106,700
+14,100
| +15% | +$313K |
|
1565
Methode Electronics
MEI
$602M
| $2.59M | ﹤0.01% |
82,800
+10,900
| +15% | +$327K |
|
|
SNBR
1566
DELISTED
Sleep Number
SNBR
| $2.58M | ﹤0.01% |
62,000
+6,900
| +13% | +$219K |
|
|
TRHC
1567
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.58M | ﹤0.01% |
47,100
+10,500
| +29% | +$601K |
|
1568
Group 1 Automotive
GPI
$3.14B
| $2.57M | ﹤0.01% |
39,000
+4,800
| +14% | +$275K |
|
1569
Coca-Cola Consolidated
COKE
$12.6B
| $2.56M | ﹤0.01% |
111,650
+15,000
| +16% | +$351K |
|
1570
Hope Bancorp
HOPE
$1.83B
| $2.56M | ﹤0.01% |
277,457
+31,700
| +13% | +$284K |
|
1571
Compugen
CGEN
$228M
| $2.56M | ﹤0.01% |
+170,200
| New | +$2.3M |
|
1572
Schrodinger
SDGR
$1.38B
| $2.56M | ﹤0.01% |
+27,900
| New | +$1.62M |
|
|
ARGO
1573
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.54M | ﹤0.01% |
72,916
+6,300
| +9% | +$210K |
|
|
CORE
1574
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.54M | ﹤0.01% |
101,700
+13,400
| +15% | +$359K |
|
1575
Madrigal Pharmaceuticals
MDGL
$12.4B
| $2.54M | ﹤0.01% |
22,400
+5,900
| +36% | +$580K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.